Evidence map›Paper›PMID 37799633›Full record

ReviewClinical liver disease2023

Epidemiology and trends of alcohol use disorder and alcohol-associated liver disease.

Elizabeth Lee, Huttakan Navadurong, Suthat Liangpunsakul

Abstract readReview
In one paragraph

Review in Clinical liver disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Non-coding RNAs in alcohol-associated liver disease.Liver research (Beijing, China) · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elizabeth LeeDivision of Gastroenterology and Hepatology, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-3118-7835
Huttakan NavadurongDivision of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID https://orcid.org/0000-0003-4627-8916
Suthat LiangpunsakulDivision of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID https://orcid.org/0000-0002-6504-8123

Funding

S-adenosylmethionine treatment in alcoholic cirrhosisU01AA026817 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI GAO, BIN, LIANGPUNSAKUL, SUTHAT · 2019 to 2024
$2.1M
FKBP5 in the pathogenesis of alcohol-associated liver diseaseR01AA030312 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI Suthat Liangpunsakul · 2022 to 2026
$1.8M
Novel biomarkers as a clinical tool for excessive alcohol use screeningR01AA025208 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT, TU, WANZHU · 2016 to 2020
$1.7M
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitisU01AA026917 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT · 2018 to 2022
$1.2M
Novel animal models to study miRNA-mediated alcoholic liver diseaseUH2AA026903 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT · 2018 to 2019
$447k
CSRD VA I01 CX000361NIAAA NIH HHS R01 AA025208NIAAA NIH HHS R01 AA030312NIAAA NIH HHS U01 AA026817NIAAA NIH HHS U01 AA026917NIAAA NIH HHS UH2 AA026903
6 · The paper itself

Abstract

1_vx2q4xfhKaltura.

Identifiers

PMID37799633
PMCPMC10550032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.